Active Matrix Metalloproteinase-8 (aMMP-8) Chair-side Test in Different Periodontal Disease
Evaluation of Active Matrix Metalloproteinase-8 (aMMP-8) Chair-side Test in Different Periodontal Disease and Healthy Implants
1 other identifier
observational
103
0 countries
N/A
Brief Summary
The aim of this study to evaluate the diagnostic accuracy of a new qualitative aMMP-8 POC test in different periodontal health and disease and as compared to the established quantitative laboratory method (ELISA)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 5, 2018
CompletedFirst Posted
Study publicly available on registry
May 17, 2018
CompletedMay 17, 2018
May 1, 2016
1 year
May 5, 2018
May 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
aMMP-8 levels of GCF
GCF levels measured by IFMA
2 hours
Secondary Outcomes (1)
Salivary MMP-8 levels
2 hours
Study Arms (5)
Chronic periodontitis
This groups participant has radiographically moderate alveolar bone loss, CAL \> 5 mm and PD \>6 mm in several sites of each quadrant
Generalized aggressive periodontitis
This demonstrated a generalized pattern of severe breakdown and CAL \> 5 mm and PD \> 6 mm on 8 \> teeth; minimum three of those were other than first incisors or first molars
Gingivitis
This group has varying degrees of gingival inflammation, with CAL \< 2 mm, without any radiographical bone loss due to periodontitis
Implant
Implants classified PD \< 5 mm, no bleeding on probing, no suppuration and no radiographic bone loss \> 0.5 mm
Health
Probing depth (PD) \< 3mm, no gingival recession due to periodontal disease, and clinical attachment level (CAL) \< 2 mm, BOP in \< 10% of full-mouth score examination
Interventions
Eligibility Criteria
All participants have minimum 20 teeth
You may qualify if:
- Systemically healthy
- Nonsmokers
You may not qualify if:
- Participants were not included if they had systemic disease such as diabetes, cardiovascular.
- Participants who took regular medications that could affect of periodontal tissue
- Participants who received antibiotics less than 10 weeks before the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 5, 2018
First Posted
May 17, 2018
Study Start
March 1, 2015
Primary Completion
March 1, 2016
Study Completion
June 1, 2016
Last Updated
May 17, 2018
Record last verified: 2016-05